Showing results (61-70 of 117) with videos related to
Sort By:
Pageof 12
Pharmacology & Therapeutics|January 13, 2009
Functional selectivity of EGF family peptide growth factors: implications for cancerKristy J Wilson, Jennifer L Gilmore, John Foley, et al.Molecular Cancer Therapeutics|August 8, 2019
Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaMarta Baro, Cecilia Lopez Sambrooks, Barbara A Burtness, et al.Developmental Biology|June 29, 2005
Computational analysis of EGFR inhibition by ArgosGregory T Reeves, Rachel Kalifa, Daryl E Klein, et al.Science Signaling|August 21, 2020
Kinetics of receptor tyrosine kinase activation define ERK signaling dynamicsAnatoly Kiyatkin, Iris K van Alderwerelt van Rosenburgh, Daryl E Klein, et al.Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
A possible effector role for the pleckstrin homology (PH) domain of dynaminKelley A Bethoney, Megan C King, Jenny E Hinshaw, et al.Expert Review of Anticancer Therapy|November 17, 2025
EGFR-TKI plus chemotherapy versus TKI monotherapy in advanced EGFR-mutant NSCLC with high PD-L1 expression: a real-world retrospective studyBosheng Su, Yuwei Xie, Yingnan Zhou, et al.Nature|August 27, 2004
Argos inhibits epidermal growth factor receptor signalling by ligand sequestrationDaryl E Klein, Valerie M Nappi, Gregory T Reeves, et al.Analytical Chemistry|February 12, 2020
Detecting Protein-Ligand Interaction from Integrated Transient Induced Molecular Electronic Signal (i-TIMES)Ping-Wei Chen, Chi-Yang Tseng, Fumin Shi, et al.Structure (London, England : 1993)|December 20, 2025
The role of kinase domain dimerization in EGFR activationZaritza O Petrova, Long Han, Yuko Tsutsui, et al.Nature Chemical Biology|September 6, 2016
Overcoming resistance to HER2 inhibitors through state-specific kinase bindingChris J Novotny, Sirkku Pollari, Jin H Park, et al.Pageof 12